ChitogenX Inc.
CHNXF · OTC
1/31/2024 | 1/31/2023 | 1/31/2022 | 1/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6,179 | $10,594 | $9,085 | $18,833 |
| - Cash | $35 | $108 | $313 | $2,379 |
| + Debt | $3,875 | $5,564 | $5,710 | $4,615 |
| Enterprise Value | $10,019 | $16,050 | $14,482 | $21,069 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$42 | -$59 | -$69 | -$89 |
| % Margin | – | – | – | – |
| EBITDA | -$2,694 | -$4,650 | -$3,188 | -$2,541 |
| % Margin | – | – | – | – |
| Net Income | -$1,554 | -$6,230 | -$4,921 | -$3,772 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.021 | -0.13 | -0.14 | -0.13 |
| % Growth | 83.6% | 7.1% | -7.7% | – |
| Operating Cash Flow | -$1,009 | -$3,197 | -$3,220 | -$2,981 |
| Capital Expenditures | $0 | $0 | -$33 | -$3 |
| Free Cash Flow | -$1,009 | -$3,197 | -$3,253 | -$2,984 |